US BANCORP \DE\ - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$59
-40.4%
350.0%0.00%
Q2 2023$99
-86.0%
35
-75.7%
0.00%
Q1 2023$707
-74.9%
144
-45.0%
0.00%
Q4 2022$2,814
+40.7%
2620.0%0.00%
Q3 2022$2,000262
+648.6%
0.00%
Q2 2022$0350.0%0.00%
Q1 2022$0350.0%0.00%
Q4 2021$0
-100.0%
35
-39.7%
0.00%
Q3 2021$1,0000.0%580.0%0.00%
Q2 2021$1,000
-66.7%
58
-71.0%
0.00%
Q3 2020$3,0000.0%2000.0%0.00%
Q2 2020$3,0000.0%2000.0%0.00%
Q1 2020$3,000
-84.2%
200
-83.3%
0.00%
Q4 2019$19,000
-13.6%
1,2000.0%0.00%
Q3 2019$22,000
-54.2%
1,200
-45.5%
0.00%
Q2 2019$48,000
+9.1%
2,2000.0%0.00%
Q1 2019$44,000
+51.7%
2,2000.0%0.00%
Q4 2018$29,0000.0%2,200
+83.3%
0.00%
Q3 2018$29,000
+190.0%
1,200
+140.0%
0.00%
Q2 2018$10,000
+66.7%
5000.0%0.00%
Q1 2018$6,000
+500.0%
500
+400.0%
0.00%
Q4 2017$1,0000.0%1000.0%0.00%
Q3 2017$1,000
-90.0%
100
-83.3%
0.00%
Q2 2017$10,0006000.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders